EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia

Willem K Smits, Carlo Vermeulen, Rico Hagelaar, Shunsuke Kimura, Eric M Vroegindeweij, Jessica G C A M Buijs-Gladdines, Ellen van de Geer, Marjon J A M Verstegen, Erik Splinter, Simon V van Reijmersdal, Arjan Buijs, Niels Galjart und 7 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Willem K Smits und 18 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, KWF Kankerbestrijding, Stichting Kinderen Kankervrij.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor T-Cell Lymphoblastic Leukemia-LymphomaHumansCCCTC-Binding FactorChromatinEnhancer Elements, GeneticMutationOncogenesRepressor ProteinsTranscription FactorsTumor Suppressor Proteins

Stichwörter der Autor:innen

BCL11BCP: CancerCTCF mutationT cell acute lymphoblastic leukemiaTLX3competitive chromatin loopingenhancer insulationoncogene regulation

Substanzen

BCL11B protein, humanCCCTC-Binding FactorChromatinRepressor ProteinsTranscription FactorsTumor Suppressor ProteinsCTCF protein, human

Autor:innen und Institutionen

  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
  • Laboratory of Pathology, St. Jude's Children's Research Hospital, Memphis TN, USA.
  • Oncode Institute, Utrecht, the Netherlands; Hubrecht Institute-KNAW, Utrecht, the Netherlands.
  • Cergentis BV, Utrecht, the Netherlands.

Förderung

  • NCI NIH HHS
  • KWF Kankerbestrijding
  • Stichting Kinderen Kankervrij
  • Stichting Kinder Oncologisch Centrum Rotterdam
  • National Cancer Institute
  • Netherlands Organization for Applied Scientific Research
  • Fondation Leducq
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Smits, W. K., Vermeulen, C., Hagelaar, R., Kimura, S., Vroegindeweij, E. M., Buijs-Gladdines, J. G. C. A. M., van de Geer, E., Verstegen, M. J. A. M., Splinter, E., van Reijmersdal, S. V., Buijs, A., Galjart, N., van Eyndhoven, W., van Min, M., Kuiper, R., Kemmeren, P., Mullighan, C. G., de Laat, W., & Meijerink, J. P. P. (2023). Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112373

Vancouver

Smits WK, Vermeulen C, Hagelaar R, Kimura S, Vroegindeweij EM, Buijs-Gladdines JGCAM, et al. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112373

BibTeX
@article{Smits2023,
  author = {Smits, Willem K and Vermeulen, Carlo and Hagelaar, Rico and Kimura, Shunsuke and Vroegindeweij, Eric M and Buijs-Gladdines, Jessica G C A M and van de Geer, Ellen and Verstegen, Marjon J A M and Splinter, Erik and van Reijmersdal, Simon V and Buijs, Arjan and Galjart, Niels and van Eyndhoven, Winfried and van Min, Max and Kuiper, Roland and Kemmeren, Patrick and Mullighan, Charles G and de Laat, Wouter and Meijerink, Jules P P},
  title = {Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112373}
}
Kostenlos starten →